» Articles » PMID: 17054590

The Prevalence of Co-morbid Depression in Adults with Type 2 Diabetes: a Systematic Review and Meta-analysis

Overview
Journal Diabet Med
Specialty Endocrinology
Date 2006 Oct 24
PMID 17054590
Citations 459
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To conduct a systematic literature review in order to estimate the prevalence and odds ratio of clinically relevant depression in adults with Type 2 diabetes compared with those without.

Methods: MEDLINE, EMBASE and PSYCINFO databases were searched using MeSH terms and free text to identify relevant controlled studies. Published reference lists were also examined. Study selection and appraisal were conducted independently by two reviewers and a meta-analysis was performed to synthesize and analyse the data.

Results: Ten controlled studies including a total of 51 331 people were published between January 1980 and May 2005. The prevalence of depression was significantly higher in patients with Type 2 diabetes compared with those without [17.6 vs. 9.8%, OR = 1.6, 95%, confidence interval (CI) 1.2-2.0]. However, in most studies, patients with diabetes differed from those without on variables known to be associated with an increased risk of depression. The prevalence of depression was higher in females with diabetes (23.8%) compared with males (12.8%); however, the odds ratio for depression in patients with Type 2 diabetes compared with those without was higher in males (OR = 1.9, 95% CI 1.7-2.1) than females (OR = 1.3, 95% CI 1.2-1.4). Failure to report potential confounders prevented a more rigorous meta-analysis of risk.

Conclusion: We identified raised rates of depression in people with Type 2 diabetes, however, there is a need for well-controlled and better-reported studies to inform the development of effective treatments for depression in these patients.

Citing Articles

High Rates of Abnormal Glucose Metabolism Detected by 75 g Oral Glucose Tolerance Test in Major Psychiatric Patients with Normal HbA1c and Fasting Glucose Levels.

Yoshida S, Aizawa E, Ishihara N, Hattori K, Segawa K, Kunugi H Nutrients. 2025; 17(4).

PMID: 40004942 PMC: 11858036. DOI: 10.3390/nu17040613.


Association of cholecystectomy with short-term and long-term risks of depression and suicide.

Yu J, Park S, Jeong S, Ko A, Lee J, Han S Sci Rep. 2025; 15(1):6557.

PMID: 39994212 PMC: 11850815. DOI: 10.1038/s41598-025-87523-5.


Investigating the role of GPR39 in treatment of stress-induced depression and anxiety.

Siodlak D, Doboszewska U, Nowak G, Wlaz P, Mlyniec K Psychopharmacology (Berl). 2025; .

PMID: 39775023 DOI: 10.1007/s00213-024-06736-0.


Associations of the Charlson comorbidity index with depression and mortality among the U.S. adults.

Wang Y, Xue C, Ma C, Liu A Front Public Health. 2024; 12:1404270.

PMID: 39664531 PMC: 11632622. DOI: 10.3389/fpubh.2024.1404270.


Incidence, prevalence and risk factors for comorbid mental illness among people with hypertension and type 2 diabetes in West Africa: protocol for a systematic review and meta-analysis.

Ayiku R, Jahan Y, Adjei-Banuah N, Antwi E, Awini E, Ohene S BMJ Open. 2024; 14(11):e081824.

PMID: 39609030 PMC: 11603740. DOI: 10.1136/bmjopen-2023-081824.